A recently completed contractor report investigating the utility of run-time assurance (RTA) architectures for electric vertical takeoff and landing (eVTOL) aircraft has been posted on NTRS, the NASA Technical Reports Server. The report summarizes a collaborative effort led by researchers from Barron Associates to demonstrate and evaluate the application of RTA to assure the safety […]
News
NOAA UAS Funding for Tropical Storm Testing
Barron Associates was awarded non-SBIR follow-on funding to their NOAA Phase II SBIR. The funding is intended to support the delivery and testing of twelve tube-deployed UASs for tropical storm monitoring in Fall 2022 and Fall 2023. The WINGSONDE UAS is deployed from a P3 aircraft tube at 250kts and 10,000 feet into the eye […]
Barron Associates Completes Multi-Site Randomized Control Trials of Video Game-based Vision Therapy System
The ICARE software system has been developed by Barron Associates, Inc. under sponsorship by the National Eye Institute as alternative intervention for addressing non-strabismic amblyopia and convergence insufficiency (CI) in children. It uses video games to create a fun and engaging vision therapy experience built on mini-games and a baby dragon quest. In January 2022, […]
Journal Paper Published on Satellite Optimal Maneuvers
Dr. Rick Adams and Dr. Michael Devore of Barron Associates, Inc. co-authored a paper titled “Finite-Thrust Natural-Motion Circumnavigation Injection by Convex Optimization” which has been published in the American Institute of Aeronautics and Astronautics (AIAA) Journal of Guidance, Control, and Dynamics. The paper details a new methodology employing convex optimization to find a propellant-optimal finite-thrust […]
Barron Associates led pain assessment study proceeds to Phase II
Evaluation and treatment for chronic pain are major contributors to rising healthcare costs. Although accurate assessment of pain and function is the cornerstone to successful chronic pain management, systematic, objective assessment of the functional impact of pain remains exceptionally challenging in practice. Barron Associates is developing and validating the KnowPain instrument. KnowPain will objectively and […]
A Novel Instrument to Address Freezing of Gait in Parkinson’s Patients
Parkinson’s Disease (PD) is a common neurodegenerative disorder that affects 1 million Americans and 10 million individuals worldwide. One of the most debilitating and impactful symptoms of PD is Freezing of Gait (FOG). Barron Associates has been awarded a grant by the National Institute on Aging to develop a body-worn system that is specially designed […]
Barron Associates awarded Phase II NIH grant to study falls in hospitals
Fall detection, assessment, and prevention is a challenging issue across the care continuum. Despite wide recognition as a considerable problem, fall-related injuries are still the most frequently reported adverse events in hospital inpatient settings. Although hospitals employ diverse programs to prevent falls and fall injuries, an essential component to a fall prevention program is accurate […]
Barron Associates Awarded NIH Funding to Develop Data Mining Tool for Healthcare Applications
The Federated Automated Survey Tool (FAST) will be an analytics platform that can be used by public health officials, clinical care investigators, institutional administrators, and others to more easily survey targeted cohorts regarding acute and chronic diseases (e.g., influenza, coronavirus, high blood pressure, etc.) and other indicators (e.g., depression prevalence, tobacco use, substance abuse, etc.) […]
A Novel, Low-Cost Mobile Metabolic Measurement (M3) System
The Barron Associates Mobile Metabolic Measurement (M3) system is an indirect calorimetry system that measures minute ventilation (VE) (i.e., the volume of gas exhaled from the lungs per minute), carbon dioxide production (VCO2), and oxygen consumption (VO2), all measured in units of liters per minute using a subject-worn face mask. In an SBIR Phase I […]
Barron Associates Completes Validation Study for Remote Oxygen Adherence Monitor (ROAM) System
Barron Associates has developed the “Remote Oxygen Adherence Monitor” (ROAM) to reliably assess long term oxygen therapy (LTOT) adherence. LTOT is associated with significant reductions in hospitalizations and improved quality of life in patients with chronic obstructive pulmonary disease (COPD). Despite the benefits of LTOT, adherence remains a challenge in the majority of patients. The […]